Aligned with India’s vision of emerging as a global pharma innovation hub, the India Pharma 2026 aims to accelerate the sector’s transition from a volume-driven model to a value- and innovation-led global powerhouse, according to an official statement on Saturday.
India Pharma 2026 event details and global collaboration focus
The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, is set to organise the 9th edition of India Pharma 2026, in association with FICCI and the Indian Pharmaceutical Alliance (IPA) on April 13-14 here, reinforcing India’s position in the global pharmaceutical industry.
The event will be inaugurated by JP Nadda, Minister of Chemicals and Fertilizers, and Anupriya Patel, Union Minister of State for Chemicals and Fertilizers.
According to the ministry, the conference serves as a platform for sectoral growth and international collaboration, focusing on India’s pharmaceutical capabilities, research and development (R&D), and the resilience of global supply chains.
India Pharma 2026 highlights life sciences innovation and R&D
The theme, titled ‘Discover in India: Leapfrogging Life-Sciences Innovation,’ highlights the transformative potential of life sciences in enhancing healthcare access, driving economic growth, and strengthening global health systems, aligning with the broader India pharma innovation hub vision.
India continues to play a pivotal role in the global supply of affordable, high-quality medicines. Building on this strong foundation, India Pharma 2026 aims to accelerate the sector’s transition from a volume-driven model to a value- and innovation-led global powerhouse, said the ministry.
Key speakers and startup showcase at India Pharma 2026
The event will witness the participation of a distinguished lineup of policymakers, industry leaders, and domain experts from across the pharmaceutical sector, highlighting the growing importance of pharmaceutical sector India on the global stage.
Prominent dignitaries include Manoj Joshi, Secretary, Department of Pharmaceuticals; Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare; and Prof. Vinod K. Paul, Member, NITI Aayog.
The event will also feature eminent domain experts such as Dr. Renu Swarup, Former Secretary, Department of Biotechnology; and Dr. Shivkumar Kalyanaraman, CEO, Anusandhan National Research Foundation (ANRF).
Apart from a dedicated special session, ‘Start-up Showcase’, the two-day event will feature six plenary sessions, further strengthening pharma events India 2026 ecosystem and innovation discussions.
Read More:
India’s pharmaceutical industry 3rd largest globally by volume, 11th by value
New Labour Codes strengthen safety and welfare ecosystem for India’s pharma industry
India to become global pharma and medtech hub to boost GDP: Jitendra Singh
